Wemos satisfied with unique ruling in case Menzis vs. AstraZeneca

14/10/2020 - News

Today the court ruled that the pharmaceutical company AstraZeneca has to refund the excessive price the company charged for the drug Seroquel to the health insurance company Menzis. The exact amount has yet to be determined. It is the first time that a health insurance company in the Netherlands has sued a pharmaceutical company.

Joint call to next European Parliament: ensure access to medicines

A group of 12 public health organizations from the European Union urges prospective Members of the European Parliament to safeguard access to affordable medicines. Wemos and Health Action International (HAI) jointly took the initiative for this call. We see that access to new medicines is increasingly under pressure in the EU due to sky-high prices. Read more

Blog

18/4/2024

CSW68 and NGO CSW68 Forum: A personal reflection on advocacy and collaboration

Our Global Health Advocate, Myria Koutsoumpa, recently attended the Commission on the Status of Women (CSW) 68 and the NGO CSW68 Forum. It was an enriching week filled with joint advocacy work, our own Make Way webinar session about access to healthcare for all and meaningful participation of youth delegates. Read more

News

5/4/2024

Reflection on debate Dutch global health strategy

Yesterday, the Committee on Foreign Trade and Development Cooperation debated the Dutch global health strategy. Wemos welcomes the focus on issues such as sexual and reproductive health and rights, and fair access to medical products worldwide, but also hopes that the incoming government will continue to recognize the importance of global health. Read more

Wemos satisfied with unique ruling in case Menzis vs. AstraZeneca

Read more news

Joint call to next European Parliament: ensure access to medicines

CSW68 and NGO CSW68 Forum: A personal reflection on advocacy and collaboration

Reflection on debate Dutch global health strategy